Gene,_SCORE_GRP2_,_SCORE_GRP1_,GRP1|6_R-HSA-156902|-5.852|Peptide chain elongation,"GRP1|33_CORUM:306|-6.007|Ribosome, cytoplasmic",GRP1|6_R-HSA-192823|-5.852|Viral mRNA Translation,GRP1|6_R-HSA-156842|-5.795|Eukaryotic Translation Elongation,GRP1|6_R-HSA-2408557|-5.795|Selenocysteine synthesis,GRP1|6_R-HSA-72764|-5.795|Eukaryotic Translation Termination,GRP1|6_R-HSA-975956|-5.767|Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),GRP1|6_R-HSA-72689|-5.688|Formation of a pool of free 40S subunits,GRP1|6_R-HSA-9633012|-5.688|Response of EIF2AK4 (GCN2) to amino acid deficiency,GRP1|33_CORUM:3055|-5.662|Nop56p-associated pre-rRNA complex,GRP1|6_R-HSA-156827|-5.565|L13a-mediated translational silencing of Ceruloplasmin expression,GRP1|6_R-HSA-1799339|-5.554|SRP-dependent cotranslational protein targeting to membrane,GRP1|6_R-HSA-72706|-5.554|GTP hydrolysis and joining of the 60S ribosomal subunit,GRP1|6_R-HSA-927802|-5.520|Nonsense-Mediated Decay (NMD),GRP1|6_R-HSA-975957|-5.520|Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),GRP1|6_R-HSA-2408522|-5.486|Selenoamino acid metabolism,GRP1|6_R-HSA-72613|-5.475|Eukaryotic Translation Initiation,GRP1|6_R-HSA-72737|-5.475|Cap-dependent Translation Initiation,GRP1|19_GO:0002181|-5.401|cytoplasmic translation,GRP1|6_R-HSA-168273|-5.312|Influenza Viral RNA Transcription and Replication,GRP1|6_R-HSA-168255|-5.124|Influenza Infection,GRP1|6_R-HSA-9711097|-5.124|Cellular response to starvation,GRP1|24_hsa03010|-5.021|Ribosome,GRP1|6_R-HSA-9010553|-5.006|Regulation of expression of SLITs and ROBOs,GRP1|6_R-HSA-6791226|-4.911|Major pathway of rRNA processing in the nucleolus and cytosol,GRP1|6_R-HSA-8868773|-4.842|rRNA processing in the nucleus and cytosol,GRP1|6_R-HSA-72312|-4.777|rRNA processing,GRP1|6_R-HSA-376176|-4.692|Signaling by ROBO receptors,GRP1|24_hsa05171|-4.611|Coronavirus disease - COVID-19,GRP1|6_R-HSA-72766|-4.319|Translation,GRP1|6_R-HSA-71291|-4.025|Metabolism of amino acids and derivatives,GRP1|19_GO:0006412|-3.940|translation,GRP1|19_GO:0043043|-3.848|peptide biosynthetic process,GRP1|19_GO:0043604|-3.525|amide biosynthetic process,GRP1|6_R-HSA-422475|-3.511|Axon guidance,GRP1|19_GO:0006518|-3.504|peptide metabolic process,GRP1|6_R-HSA-9675108|-3.454|Nervous system development,GRP1|6_R-HSA-8953854|-3.154|Metabolism of RNA,GRP2|19_GO:0034248|-3.573|regulation of amide metabolic process,GRP2|19_GO:0034249|-4.606|negative regulation of amide metabolic process,_SORT_,_SORT_GRP1_,_SORT_GRP2_
6139,0.0,1.0,0.3,0.4,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.2,0.2,0.2,0.2,0.2,0.2,0.2,0.0,0.0,3,2,0
1191,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.3,5,0,2
6217,0.0,1.0,0.3,0.4,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.2,0.2,0.2,0.2,0.2,0.2,0.2,0.0,0.0,2,1,0
10140,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.3,4,0,1
23521,1.0,1.0,0.3,0.4,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.3,0.2,0.2,0.2,0.2,0.2,0.2,0.2,0.2,0.3,1,3,3
